Tim Andrews

Tim Andrews is the Chief Legal Officer at Mirador Therapeutics since December 2023, where the focus is on precision medicine in immunology and inflammation. Prior to this role, Tim served as General Counsel at Prometheus Biosciences, Inc. from November 2020 to June 2023, overseeing the company's IPO and its acquisition by Merck. Tim was also General Counsel at Sienna Biopharmaceuticals from June 2016 to December 2019, and held the position of Senior Corporate Counsel at Allergan from January 2011 to June 2015, leading significant business development transactions and managing SEC compliance during Allergan's acquisition by Actavis. Tim's earlier experience includes working as an associate at Latham & Watkins and as a business analyst at Deloitte Consulting. Tim holds a B.A. in Political Economy from the University of California, Berkeley and a J.D. from Loyola Law School, Los Angeles.